AXRX Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.15 - $0.16
Previous CloseN/A
Volume2.20K
Average Volume (3M)0.00
Market Cap
$33.88K
Enterprise Value$41.22M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)0.5
Beta-0.83
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding169,410,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio4.87
Price to Book (P/B)50.40
Price to Sales (P/S)3.90
P/FCF Ratio1.48K
Enterprise Value/Market Cap1.22K
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AXRX FAQ
What was Amexdrug Corporation’s price range in the past 12 months?
Amexdrug Corporation lowest stock price was $0.15 and its highest was $0.16 in the past 12 months.
What is Amexdrug Corporation’s market cap?
Amexdrug Corporation’s market cap is $33.88K.
When is Amexdrug Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Amexdrug Corporation’s earnings last quarter?
Currently, no data Available
Is Amexdrug Corporation overvalued?
According to Wall Street analysts Amexdrug Corporation’s price is currently Overvalued.
Does Amexdrug Corporation pay dividends?
Amexdrug Corporation does not currently pay dividends.
What is Amexdrug Corporation’s EPS estimate?
Amexdrug Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amexdrug Corporation have?
Amexdrug Corporation has 169,410,000 shares outstanding.
What happened to Amexdrug Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Amexdrug Corporation?
Currently, no hedge funds are holding shares in AXRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amexdrug Corporation
Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this core function, Amexdrug is also deeply involved in the entire lifecycle of pharmaceutical drugs, cosmetics, and medical devices, from their research and development phases through manufacturing and ultimate sale. The company's operations are divided into two main divisions: Distribution and Health and Beauty Products. Its extensive distribution network encompasses a wide range of items, including prescription and over-the-counter medications, various non-drug products, and health and beauty essentials. Amexdrug also provides services in private manufacturing and labeling. Specific product lines manufactured and sold by the company, often under its Sponix brand, include facial and body creams, arthritic pain relief treatments, and hair and nail care products. These goods are supplied to a diverse clientele such as pharmacies, beauty salons, beauty supply outlets, and other retail establishments. Within the state of California, Amexdrug's distribution channels primarily target independent pharmacies, extending secondarily to smaller pharmacy chains, alternative care facilities, and various wholesalers and retailers. The company adopted the name Amexdrug Corporation in April 2000, changing from its previous identity as Harlyn Products, Inc., to reflect its strategic focus on pharmaceutical sales.
Technical Analysis
China Pharma Holdings
―
RedHill Biopharma
―
PainReform
―
Universe Pharmaceuticals
―
Shuttle Pharmaceuticals Holdings, Inc.
―